Lund, Sweden

Martin Lindsjö

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Martin Lindsjö: Innovator in Neutrophil Elastase Inhibition

Introduction

Martin Lindsjö is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit human neutrophil elastase. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Lindsjö holds 2 patents that focus on novel compounds with therapeutic applications. His latest patents include "Some 2-pyrazinone derivatives and their use as inhibitors of neutrophil elastase." This invention provides certain novel compounds, along with their pharmaceutically acceptable salts and specific forms. The compounds are designed to inhibit human neutrophil elastase, which plays a crucial role in various inflammatory processes. Another patent involves "2-pyridone compounds," which also serve as inhibitors of human neutrophil elastase. This patent outlines the compounds' formulas and the processes for their preparation, emphasizing their potential therapeutic uses.

Career Highlights

Martin Lindsjö is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative drug development, particularly in the area of elastase inhibition. His contributions have been instrumental in advancing therapeutic options for conditions related to inflammation.

Collaborations

Lindsjö has collaborated with notable colleagues, including David Chapman and Hans Lönn. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in their field.

Conclusion

Martin Lindsjö is a prominent inventor whose work in developing neutrophil elastase inhibitors has the potential to impact therapeutic practices significantly. His patents reflect a commitment to innovation in pharmaceutical sciences, contributing to the ongoing fight against inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…